eupraxiapharma.com - EPRX Sales Growth YoY (TTM)

Brandmark of Eupraxia Pharmaceuticals, Inc. (EPRX)

Management's focus on developing innovative analgesics for arthritis drives the price action on the GURU.Markets chart for Eupraxia Pharmaceuticals (EPRX). The last twelve months (LTM) trading revenue growth is currently 0.00, reflecting the most recent value of the metric. The business foundation is based on the expansion of the DiffuX platform for treating inflammation and the utilization of external manufacturing plants while maintaining control over microsphere technology.

EPRX: Eupraxia Pharmaceuticals Sales Growth YoY (Last Twelve Months) 11/23/2025 - 11/18/2026

eupraxiapharma.com - analytical breakdowns and key metrics (EPRX)

- market value and analyst target forecast:
Summary company analytics:EPRX eupraxiapharma.com
Original product of Eupraxia Pharmaceuticals

This indicator measures revenue dynamics over a rolling four-quarter period, neutralizing seasonality and identifying structural changes in business cash flows through daily recalculations. For Eupraxia Pharmaceuticals (EPRX), the year-over-year sales growth rate over the rolling 4 quarters reflects the commercial expansion of the DiffuX platform and the extent of licensees' reliance on prolonged formulas, where an accelerating trend confirms the technology's market dominance.

Who Eupraxia Pharmaceuticals competes with

Sales Growth YoY (TTM) Haleon Corp HLN|Kenvue Inc - Sales Growth YoY (TTM)|Trailing Twelve Months Revenue Growth veronapharma.com|Jyong Bio (MENS) - Sales Growth YoY (Last Twelve Months)|Revenue Growth Rate YoY (Last Twelve Months) Ligand LGND|AMRX (amneal.com) - Sales Growth YoY (TTM)|PRGO: Revenue Dynamics YoY (Last Twelve Months)|Revenue Growth YoY (Last 12 Months) ALVO (Alvotech Corp)|Annual Revenue Growth (Last Twelve Months) Liquidia Corporation|Sales Growth YoY (TTM) GLPG (glpg.com)|Revenue Dynamics YoY (Last Twelve Months) ANIP|MNKD - Sales Growth YoY (Last Twelve Months)|Amphastar - Revenue Change YoY (Last 12 Months)|PCRX: Sales Growth YoY (TTM)|ars-pharma.com - Revenue Dynamics YoY (Last Twelve Months)|TBPH (Theravance Biopharma Inc) - Sales Growth YoY (TTM)|Trailing Twelve Months Revenue Growth Aquestive Pharma AQST|Sales Growth YoY (TTM) SCPH|Revenue Change YoY (Last 12 Months) TECX|Sales Growth YoY (Last Twelve Months) tonixpharma.com TNXP|SXTC (SXT China) - Trailing Twelve Months Sales Growth|BHST - Sales Growth YoY (Last Twelve Months)|eXoZymes (EXOZ) - Revenue Growth YoY (Last 12 Months)|ORMP: Sales Growth YoY (TTM)|ENTX: Revenue Change YoY (Last 12 Months)|HYFT (ipatherapeutics.com) - Sales Growth YoY (TTM)|Sales Growth YoY (TTM) ABVC BioPharma|Sales Growth YoY (Last Twelve Months) Cumberland Pharmaceuticals Inc. (CPIX)|QNTM (Quantum BioPharma Ltd.) - Revenue Dynamics YoY (Last Twelve Months)|Sales Growth YoY (TTM) FGEN (fibrogen.com)|Telomir Pharmaceuticals (TELO) - Trailing Twelve Months Revenue Growth|RANI - Sales Growth YoY (Last Twelve Months)|Annual Revenue Growth (Last Twelve Months) Synergy CHC SNYR|RLYB: Sales Growth YoY (TTM)|Trailing Twelve Months Revenue Growth Lexaria (LEXX)|Sales Growth YoY (Last Twelve Months) Pulmatrix|Sales Growth YoY (Last 12 Months) PTHL (ftzy.com.cn)|Sales Growth YoY (TTM) APM|Lyra Therapeutics, Inc. - Sales Growth YoY (Last 12 Months)|Sales Growth YoY (TTM) IBO (impactbiomedinc.com)|TNFA: Sales Growth YoY (Last 12 Months)|YCBD - Sales Growth YoY (Last Twelve Months)|PRFX - Sales Growth YoY (TTM)|CYTO (altamiratherapeutics.com) - Revenue Growth YoY (Last 12 Months)|LIPO - Annual Revenue Growth (Last Twelve Months)|Revenue Growth YoY (Last 12 Months) OPTN|Pieris Pharmaceuticals Inc (PIRS) - Annual Revenue Growth (Last Twelve Months)|Sales Growth YoY (TTM) PROC|PTPI: Trailing Twelve Months Sales Growth|Sales Growth YoY (Last Twelve Months) Qilian International QLI|Revenue Change YoY (Last 12 Months) SLRN (Acelyrin, Inc.)|TFFP - Sales Growth YoY (Last Twelve Months)